Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

VHUB attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:55 UTC
  • 15
  • 0 comments

VHUB attributes changed: Attr: Fin_status N -> D;

Comment Full text

SPRC attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:54 UTC
  • 13
  • 0 comments

SPRC attributes changed: Attr: Fin_status D -> N;

Comment Full text

SCISPARC LTD. (SPRC)

  • Technical Exchange News
  • May 08, 2026, 01:54 UTC
  • 15
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

INV attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:53 UTC
  • 15
  • 0 comments

INV attributes changed: Attr: Fin_status N -> D;

Comment Full text

HOTH THERAPEUTICS, INC. (HOTH)

  • Technical Exchange News
  • May 08, 2026, 01:53 UTC
  • 15
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

HOTH attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:53 UTC
  • 20
  • 0 comments

HOTH attributes changed: Attr: Fin_status N -> D;

Comment Full text

ATARA BIOTHERAPEUTICS, INC. (ATRA)

  • Technical Exchange News
  • May 08, 2026, 01:52 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ATRA attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:52 UTC
  • 24
  • 0 comments

ATRA attributes changed: Attr: Fin_status N -> D;

Comment Full text

ALIS attributes changed

  • Technical Exchange News
  • May 08, 2026, 01:52 UTC
  • 17
  • 0 comments

ALIS attributes changed: Attr: Fin_status N -> D;

Comment Full text

SCISPARC LTD. (SPRC)

  • Technical Exchange News
  • May 08, 2026, 01:47 UTC
  • 13
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 181
  • 182
  • 183
  • 184
  • 185
  • Next

Search

News categories

  • Technical Exchange News(14174)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222313)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin